| Code | CSB-RA884484MB1HU |
| Size | US$9799 |
| Order now | |
| Have Questions? | Leave a Message or Start an on-line Chat |
This recombinant monoclonal antibody is a research-grade biosimilar to HMBD-002, designed for research targeting VSIR (V-Set Immunoregulatory Receptor), also known as VISTA or PD-1H. VSIR functions as an immune checkpoint protein predominantly expressed on myeloid cells and a subset of T cells, where it delivers inhibitory signals that suppress T cell activation and proliferation. This receptor plays a critical role in maintaining immune homeostasis and preventing excessive inflammatory responses. VSIR has emerged as a significant target in immuno-oncology research, as its expression in the tumor microenvironment contributes to immune evasion mechanisms in various cancers, including melanoma, colorectal cancer, and non-small cell lung cancer.
HMBD-002 represents a therapeutic antibody candidate developed to block VSIR-mediated immunosuppression, thereby enhancing anti-tumor immune responses. This biosimilar provides researchers with a valuable tool for investigating VSIR biology, exploring immune checkpoint mechanisms, and evaluating potential therapeutic strategies in cancer immunology and autoimmune disease models. The antibody enables detailed characterization of VSIR's role in immune regulation and tumor progression across diverse experimental systems.
There are currently no reviews for this product.